A preclinical study reports a platform for the generation of dendritic cell-derived nanovesicles with enhanced immunostimulatory function, which demonstrate promising antitumoural activity in mouse models and might overcome some of the shortcomings of early-generation dendritic cell nanovaccines.

中文翻译：

---

促进树突状细胞纳米疫苗

一项临床前研究报告了一个生成具有增强免疫刺激功能的树突状细胞衍生纳米囊泡的平台，该平台在小鼠模型中显示出有希望的抗肿瘤活性，并可能克服早期产生的树突状细胞纳米疫苗的一些缺点。